Ruibo Bio-B (06938) received a further increase in H shares by 6800 shares by director Gan Liming

Zhitong Finance App News, Ruibo Bio-B (06938) announced that the board of directors was recently informed by Dr. Gan Liming, the company's executive director, co-CEO and president of global R&D, that Dr. Gan Liming further purchased 6,800 H shares of the company in the open market with his own capital. Following the increase in holdings, as of July 10, 2026, Dr. Gan Liming has purchased a total of 20,000 H shares in the open market with his own capital.

Dr. Gan Liming said he is confident about the Group's overall development prospects and potential growth. In compliance with applicable laws and regulatory requirements, Dr. Gan Liming will not rule out further increasing the company's shares in due course.